Only a few hundred cases of polio are reported each year, but a synthetic vaccine could be the key to eradicate it for good. Scientists are teaming up to develop a synthetic vaccine in an effort to address some limitations of the existing oral vaccine.
United Kingdom-based Immune Targeting Systems (ITS) showed data from a Phase IIa trial of its candidate, Flunisyn, at the World Vaccine Congress this week.
Sanofi Pasteur will join University of Pittsburgh scientists to develop a vaccine for all strains of seasonal influenza that will take as little as four months to produce.
A team of U.S. researchers has created a synthetic vaccine that was effective in treated animals with HPV-derived cancer, and could be a step towards a cancer treatment with fewer side effects, according to a paper published in Cancer Immunology, Immunotherapy.